Menopausal State in Breast Cancer: How Reliable is the Data?

被引:2
|
作者
Moffat, Rebecca Elizabeth [2 ]
Eichholzer, Monika [3 ]
Myrick, Mary Elizabeth [2 ]
Schmid, Seraina Margaretha [2 ]
Raggi, Anna [2 ]
De Geyter, Christian [2 ]
Schoetzau, Andreas [4 ]
Gueth, Uwe [1 ,2 ]
机构
[1] Cantonal Hosp Winterthur, Dept Gynecol & Obstet, CH-8401 Winterthur, Switzerland
[2] Univ Basel Hosp, Dept Gynecol & Obstet, CH-4031 Basel, Switzerland
[3] Univ Zurich, Inst Social & Prevent Med, CH-8006 Zurich, Switzerland
[4] Schotzau & Simmen Inst Biomath, Basel, Switzerland
关键词
Breast cancer; Endocrine therapy; Epidemiology; Menopause; Menopausal state; HORMONE REPLACEMENT THERAPY; RISK-FACTORS; WOMEN; AGE; HYSTERECTOMY; DEFINITION; TRANSITION; BIAS;
D O I
10.1016/j.clbc.2011.07.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Despite the high importance of the menopausal state for the management of breast cancer, above all, when planning antihormonal adjuvant therapy, the menopausal state cannot be defined at the time of diagnosis in a significant proportion of women. The scope of uncertainties regarding the recording of the menopausal state in a cohort of patients with breast cancer is evaluated. Introduction: Menopause is a cornerstone both in breast cancer (BC) pathophysiology and in clinical management. The scope of uncertainties regarding the recording of the menopausal state in a cohort of patients with BC is evaluated in this study. Patients and Methods: The data of a Swiss prospective relational BC database that covered a 20-year period (1990-2009; n = 1457) was analyzed. For the definition of menopause, the guidelines of the National Comprehensive Cancer Network were used. Results: The menopausal state was unclear in 150 patients (10.2%). Of these, 122 (81.3%) had undergone a hysterectomy before menopause; in 28 women (18.7%), an endocrine therapy obscured the patient's actual endocrine status. When taking only the subgroup of women in which menopause usually occurs (45-55 years) into consideration, the menopausal state was unclear in 91 cases of 337 women (27.0%). From the entire cohort, the date of last menstruation remained obscure in 450 patients (30.9%). Conclusion: Despite the high importance of the menopausal state for the management of BC, above all, when planning antihormonal adjuvant therapy, the menopausal state was unable to be defined at the time of BC diagnosis in a significant proportion of women. The dilemma that menopause cannot be assessed in some BC cases is increasingly being recognized. Close cooperation between oncologists and endocrinologists is desirable to establish an optimal, individually tailored therapy for women with an unclear menopausal state due to hormonal therapies, hysterectomy, or chemotherapy. Clinical Breast Cancer, Vol. 11, No. 6, 390-4 (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:390 / 394
页数:5
相关论文
共 50 条
  • [21] New State of Data on primary metastatic Breast Cancer
    Barinoff, Jana
    Thill, Marc
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2014, 74 (02) : 127 - 129
  • [22] Menopausal Estrogen Therapy and Breast Cancer Mortality
    Hickey, Martha
    McNamara, Helen C.
    Mishra, Gita D.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (02): : 193 - 193
  • [23] Menopausal hot flushes after breast cancer
    Fenlon, D. R.
    Corner, J. L.
    Haviland, J.
    EUROPEAN JOURNAL OF CANCER CARE, 2009, 18 (02) : 140 - 148
  • [24] Menopausal hormone therapy after breast cancer
    Colditz, GA
    BREAST CANCER RESEARCH, 2005, 7 (04) : 168 - 170
  • [25] Menopausal hormones and breast cancer in a biracial population
    Moorman, PG
    Kuwabara, H
    Millikan, RC
    Newman, B
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2000, 90 (06) : 966 - 971
  • [26] Menopausal hormones: definitive evidence for breast cancer
    Kotsopoulos, Joanne
    LANCET, 2019, 394 (10204): : 1116 - 1118
  • [27] Menopausal hormone therapy and breast cancer risk
    Mallmann, P.
    Nitschmann, S.
    INTERNIST, 2020, 61 (06): : 647 - 650
  • [28] Managing menopausal symptoms after breast cancer
    Kubista, E
    Seifert, M
    MIDLIFE HEALTH - CURRENT CONCEPTS AND CHALLENGES FOR THE FUTURE, 2002, 1229 : 151 - 155
  • [29] Treatments for menopausal symptoms in breast cancer patients
    Hunter, MS
    PROCEEDINGS OF THE 14TH INTERNATIONAL CONFERENCE OF PSYCHOSOMATIC OBSTETRICS AND GYNAECOLOGY, 2004, : 87 - 91
  • [30] Menopausal hormone therapy and breast cancer risk
    Rozenberg, Serge
    Di Pietrantonio, Victoria
    Vandromme, Jean
    Gilles, Christine
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 35 (06)